Schonfeld Strategic Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,590
| Closed | -$296K | – | 2236 |
|
|
2025
Q1 | $296K | Sell |
41,590
-103,912
| -71% | -$739K | ﹤0.01% | 1666 |
|
|
2024
Q4 | $1.7M | Buy |
145,502
+10,223
| +8% | +$119K | 0.01% | 843 |
|
|
2024
Q3 | $2.78M | Sell |
135,279
-51,161
| -27% | -$1.05M | 0.02% | 635 |
|
|
2024
Q2 | $4.17M | Buy |
186,440
+160,719
| +625% | +$3.6M | 0.03% | 527 |
|
|
2024
Q1 | $708K | Buy |
+25,721
| New | +$708K | ﹤0.01% | 1180 |
|
|
2023
Q4 | – | Sell |
-10,960
| Closed | -$347K | – | 1965 |
|
|
2023
Q3 | $347K | Sell |
10,960
-39,118
| -78% | -$1.24M | ﹤0.01% | 1173 |
|
|
2023
Q2 | $2.04M | Buy |
50,078
+12,851
| +35% | +$524K | 0.02% | 745 |
|
|
2023
Q1 | $1.39M | Buy |
+37,227
| New | +$1.39M | 0.01% | 805 |
|
|
2022
Q4 | – | Sell |
-21,970
| Closed | -$1.23M | – | 2770 |
|
|
2022
Q3 | $1.23M | Sell |
21,970
-22,930
| -51% | -$1.28M | 0.01% | 1125 |
|
|
2022
Q2 | $2.32M | Buy |
44,900
+21,000
| +88% | +$1.09M | 0.02% | 648 |
|
|
2022
Q1 | $1.74M | Buy |
+23,900
| New | +$1.74M | 0.02% | 738 |
|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$810K | – | 2207 |
|
|
2021
Q2 | $810K | Buy |
+5,000
| New | +$810K | 0.01% | 961 |
|
|
2021
Q1 | – | Sell |
-31,880
| Closed | -$1.73M | – | 1968 |
|
|
2020
Q4 | $1.73M | Buy |
+31,880
| New | +$1.73M | 0.02% | 606 |
|
|
2018
Q1 | – | Sell |
-11,424
| Closed | -$220K | – | 894 |
|
|
2017
Q4 | $220K | Buy |
+11,424
| New | +$220K | 0.02% | 649 |
|
|
2016
Q3 | – | Sell |
-10,443
| Closed | -$223K | – | 500 |
|
|
2016
Q2 | $223K | Buy |
+10,443
| New | +$223K | 0.05% | 364 |
|